{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:09:52Z","timestamp":1740164992954,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Basque Government, Basque Modeling Task Force Project","award":["BERC 2022-2025","BERC 2022-2025","BERC 2022-2025","BERC 2022-2025","BERC 2022-2025"],"award-info":[{"award-number":["BERC 2022-2025","BERC 2022-2025","BERC 2022-2025","BERC 2022-2025","BERC 2022-2025"]}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["RYC2021-031380-I"],"award-info":[{"award-number":["RYC2021-031380-I"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EITB Marathon 2021 call","award":["BIO21\/COV\/001"],"award-info":[{"award-number":["BIO21\/COV\/001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Epidemiol Glob Health"],"DOI":"10.1007\/s44197-024-00286-6","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T10:02:17Z","timestamp":1724666537000},"page":"1289-1299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of High Covid-19 Vaccination Rate in an Aging Population: Estimating Averted Hospitalizations and Deaths in the Basque Country, Spain Using Counterfactual Modeling"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3444-0242","authenticated-orcid":false,"given":"Carlo Delfin S.","family":"Estadilla","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9455-4869","authenticated-orcid":false,"given":"Javier","family":"Mar","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3310-719X","authenticated-orcid":false,"given":"Oliver","family":"Ibarrondo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9315-5586","authenticated-orcid":false,"given":"Nico","family":"Stollenwerk","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8354-9944","authenticated-orcid":false,"given":"Ma\u00edra","family":"Aguiar","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"key":"286_CR1","unstructured":"EUSTAT. Statistical overview of elderly persons. [Accessed 09-April-2024]. https:\/\/en.eustat.eus\/estadisticas\/tema_1280\/opt_1\/ti_statistical-overview-of-elderly-persons\/temas.html"},{"key":"286_CR2","unstructured":"World Bank. Population ages 65 and above (% of total population). [Accessed 09-April-2024]. https:\/\/data.worldbank.org\/indicator\/SP.POP. 65UP.TO.ZS"},{"key":"286_CR3","unstructured":"World Health Organization. Case Study: The Age-friendly Programme in Basque Country (Euskadi). [Accessed 19-June-2024]."},{"key":"286_CR4","unstructured":"EUSTAT. Poblaci\u00f3n. [Accessed 09-April-2024]. https:\/\/es.eustat.eus\/bancopx\/spanish\/id_2212\/indiceRR.html"},{"key":"286_CR5","unstructured":"Minder R. Spain becomes latest epicenter of coronavirus after a faltering response. [Accessed 09-April-2024]. https:\/\/www.nytimes.com\/2020\/03\/13\/world\/europe\/spain-coronavirus-emergency.html"},{"key":"286_CR6","unstructured":"Departamento de Salud, Euskadi. Boletin Oficial del Pa\u00eds Vasco, Decreto 36.2020. [Accessed 09-April-2024]. https:\/\/www.euskadi.eus\/normativa-de-medidas-excepcionales-adoptadas-por-el-nuevo-coronavirus-covid-19\/web01-a2korona\/es\/"},{"key":"286_CR7","unstructured":"La Moncloa. El Gobierno decreta un estado de alarma para dar amparo constitucional pleno a las medidas contra la pandemia necesarias en las CC.AA. [Accessed 27-May-2024]. https:\/\/www.lamoncloa.gob.es\/presidente\/actividades\/Paginas\/2020\/251020estado-alarma.aspx"},{"key":"286_CR8","unstructured":"OPEN DATA EUSKADI. Evoluci\u00f3n del coronavirus (COVID-19) en Euskadi. [Accessed 09-April-2024]. https:\/\/opendata.euskadi.eus\/catalogo\/-\/evolucion-del-coronavirus-covid-19-en-euskadi\/"},{"issue":"10","key":"286_CR9","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1056\/nejmoa2117128","volume":"386","author":"DY Lin","year":"2022","unstructured":"Lin DY, Gu Y, Wheeler B, Young H, Holloway S, Sunny SK, et al. Effectiveness of Covid-19 vaccines over a 9-Month period in North Carolina. N Engl J Med. 2022;386(10):933\u201341. https:\/\/doi.org\/10.1056\/nejmoa2117128.","journal-title":"N Engl J Med"},{"issue":"9","key":"286_CR10","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/nejmoa2117608","volume":"386","author":"J Sadoff","year":"2022","unstructured":"Sadoff J, Gray G, Vandebosch A, C\u00e1rdenas V, Shukarev G, Grinsztejn B, et al. Final analysis of efficacy and safety of single-dose Ad26.COV2.S. N Engl J Med. 2022;386(9):847\u201360. https:\/\/doi.org\/10.1056\/nejmoa2117608.","journal-title":"N Engl J Med"},{"issue":"10319","key":"286_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0140-6736(21)02754-9","volume":"399","author":"SV Katikireddi","year":"2022","unstructured":"Katikireddi SV, Cerqueira-Silva T, Vasileiou E, Robertson C, Amele S, Pan J, et al. Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil. Lancet. 2022;399(10319):25\u201335. https:\/\/doi.org\/10.1016\/s0140-6736(21)02754-9.","journal-title":"Lancet"},{"issue":"2","key":"286_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.cmi.2021.10.005","volume":"28","author":"T Fiolet","year":"2022","unstructured":"Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infec. 2022;28(2):202\u201321. https:\/\/doi.org\/10.1016\/j.cmi.2021.10.005.","journal-title":"Clin Microbiol Infec"},{"key":"286_CR13","doi-asserted-by":"publisher","unstructured":"Vilches TN, Abdollahi E, Cipriano LE, Haworth-Brockman M, Keynan Y, Sheffield H, et al. Impact of non-pharmaceutical interventions and vaccination on COVID-19 outbreaks in Nunavut, Canada: a Canadian Immunization Research Network (CIRN) study. BMC Public Health. 2022;22(1). https:\/\/doi.org\/10.1186\/s12889-022-13432-1.","DOI":"10.1186\/s12889-022-13432-1"},{"key":"286_CR14","doi-asserted-by":"publisher","first-page":"100085","DOI":"10.1016\/j.lana.2021.100085","volume":"5","author":"A Shoukat","year":"2022","unstructured":"Shoukat A, Vilches TN, Moghadas SM, Sah P, Schneider EC, Shaff J, et al. Lives saved and hospitalizations averted by COVID-19 vaccination in New York City: a modeling study. Lancet Reg Health Am. 2022;5:100085. https:\/\/doi.org\/10.1016\/j.lana.2021.100085.","journal-title":"Lancet Reg Health Am"},{"key":"286_CR15","doi-asserted-by":"publisher","first-page":"100397","DOI":"10.1016\/j.lana.2022.100397","volume":"17","author":"LS Ferreira","year":"2023","unstructured":"Ferreira LS, Darcie Marquitti FM, Paix\u00e3o da Silva RL, Borges ME, Ferreira da Costa Gomes M, Cruz OG, et al. Estimating the impact of implementation and timing of the COVID-19 vaccination programme in Brazil: a counterfactual analysis. Lancet Reg Health Am. 2023;17:100397. https:\/\/doi.org\/10.1016\/j.lana.2022.100397.","journal-title":"Lancet Reg Health Am"},{"key":"286_CR16","doi-asserted-by":"publisher","first-page":"100418","DOI":"10.1016\/j.lana.2022.100418","volume":"17","author":"N Santos CVBd","year":"2023","unstructured":"Santos CVBd N, TGd, Werneck GL, Struchiner CJ, Villela DAM. Estimated COVID-19 severe cases and deaths averted in the first year of the vaccination campaign in Brazil: a retrospective observational study. Lancet Reg Health Am. 2023;17:100418. https:\/\/doi.org\/10.1016\/j.lana.2022.100418.","journal-title":"Lancet Reg Health Am"},{"key":"286_CR17","doi-asserted-by":"publisher","first-page":"100571","DOI":"10.1016\/j.lanwpc.2022.100571","volume":"28","author":"T Kayano","year":"2022","unstructured":"Kayano T, Sasanami M, Kobayashi T, Ko YK, Otani K, Suzuki M, et al. Number of averted COVID-19 cases and deaths attributable to reduced risk in vaccinated individuals in Japan. Lancet Reg Health Am West Pac. 2022;28:100571. https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100571.","journal-title":"Lancet Reg Health Am West Pac"},{"issue":"9","key":"286_CR18","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/s1473-3099(22)00320-6","volume":"22","author":"OJ Watson","year":"2022","unstructured":"Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022;22(9):1293\u2013302. https:\/\/doi.org\/10.1016\/s1473-3099(22)00320-6.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"286_CR19","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.3201\/eid2809.212226","volume":"28","author":"D He","year":"2022","unstructured":"He D, Ali ST, Fan G, Gao D, Song H, Lou Y, et al. Evaluation of effectiveness of global COVID-19 vaccination campaign. Emerg Infect Dis. 2022;28(9):1873\u20136. https:\/\/doi.org\/10.3201\/eid2809.212226.","journal-title":"Emerg Infect Dis"},{"key":"286_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-023-01326-y","author":"J Mar","year":"2023","unstructured":"Mar J, Ibarrondo O, Estadilla CDS, Stollenwerk N, Anto\u00f1anzas F, Blasco-Aguado R, et al. Cost-effectiveness analysis of vaccines for COVID-19 according to sex, Comorbidity and Socioeconomic Status: a Population Study. PharmacoEconomics. 2023. https:\/\/doi.org\/10.1007\/s40273-023-01326-y.","journal-title":"PharmacoEconomics"},{"key":"286_CR21","doi-asserted-by":"publisher","unstructured":"Aguiar M, Ortuondo EM, Van-Dierdonck JB, Mar J, Stollenwerk N. Modelling COVID 19 in the Basque Country from introduction to control measure response. Sci Rep-UK. 2020;10(1). https:\/\/doi.org\/10.1038\/s41598-020-74386-1.","DOI":"10.1038\/s41598-020-74386-1"},{"key":"286_CR22","doi-asserted-by":"publisher","unstructured":"Aguiar M, Van-Dierdonck JB, Mar J, Cusimano N, Knopoff D, Anam V, et al. Critical fluctuations in epidemic models explain COVID-19 post-lockdown dynamics. Sci Rep-UK. 2021;11(1). https:\/\/doi.org\/10.1038\/s41598-021-93366-7.","DOI":"10.1038\/s41598-021-93366-7"},{"issue":"2","key":"286_CR23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/jebm.12525","volume":"16","author":"Y Fu","year":"2023","unstructured":"Fu Y, Zhao J, Han P, Zhang J, Wang Q, Wang Q, et al. Cost-effectiveness of COVID-19 vaccination: a systematic review. J Evid-Based Med. 2023;16(2):152\u201365. https:\/\/doi.org\/10.1111\/jebm.12525.","journal-title":"J Evid-Based Med"},{"key":"286_CR24","doi-asserted-by":"publisher","unstructured":"Utami AM, Rendrayani F, Khoiry QA, Noviyanti D, Suwantika AA, Postma MJ, et al. Economic evaluation of COVID-19 vaccination: a systematic review. J Glob Health. 2023;13. https:\/\/doi.org\/10.7189\/jogh.13.06001.","DOI":"10.7189\/jogh.13.06001"},{"issue":"2","key":"286_CR25","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.idm.2023.03.002","volume":"8","author":"N Stollenwerk","year":"2023","unstructured":"Stollenwerk N, Estadilla CDS, Mar J, Van-Dierdonck JB, Ibarrondo O, Blasco-Aguado R, et al. The effect of mixed vaccination rollout strategy: a modelling study. Infec Dis Model. 2023;8(2):318\u201340. https:\/\/doi.org\/10.1016\/j.idm.2023.03.002.","journal-title":"Infec Dis Model"},{"key":"286_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jare.2021.10.012","volume":"39","author":"M Aguiar","year":"2022","unstructured":"Aguiar M, Van-Dierdonck JB, Mar J, Stollenwerk N. The role of mild and asymptomatic infections on COVID-19 vaccines performance: a modeling study. J Adv Res. 2022;39:157\u201366. https:\/\/doi.org\/10.1016\/j.jare.2021.10.012.","journal-title":"J Adv Res"},{"issue":"7","key":"286_CR27","doi-asserted-by":"publisher","first-page":"e0267772","DOI":"10.1371\/journal.pone.0267772","volume":"17","author":"AK Srivasrav","year":"2022","unstructured":"Srivasrav AK, Stollenwerk N, Bidaurrazaga Van-Dierdonck J, Mar J, Ibarrondo O, Aguiar M. Modeling the initial phase of COVID-19 epidemic: the role of age and disease severity in the Basque Country, Spain. PLoS ONE. 2022;17(7):e0267772. https:\/\/doi.org\/10.1371\/journal.pone.0267772.","journal-title":"PLoS ONE"},{"key":"286_CR28","unstructured":"D\u2019Errico J. fminsearchbnd, fminsearchcon. MATLAB Central File Exchange. [Accessed 09-April-2024]. https:\/\/www.mathworks.com\/matlabcentral\/fileexchange\/8277-fminsearchbnd-fminsearchcon"},{"issue":"1","key":"286_CR29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jtbi.2008.04.011","volume":"254","author":"S Marino","year":"2008","unstructured":"Marino S, Hogue IB, Ray CJ, Kirschner DE. A methodology for performing global uncertainty and sensitivity analysis in systems biology. J Theor Biol. 2008;254(1):178\u201396. https:\/\/doi.org\/10.1016\/j.jtbi.2008.04.011.","journal-title":"J Theor Biol"},{"issue":"1","key":"286_CR30","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1080\/17513758.2018.1535096","volume":"12","author":"AA de los Reyes","year":"2018","unstructured":"de los Reyes AA, Escaner JML. Dengue in the Philippines: model and analysis of parameters affecting transmission. J Biol Dynam. 2018;12(1):894\u2013912. https:\/\/doi.org\/10.1080\/17513758.2018.1535096.","journal-title":"J Biol Dynam"},{"key":"286_CR31","unstructured":"National Center for Immunization and Respiratory Diseases. COVID-19 can surge throughout the year. U.S. Centers for Disease Control and Prevention. [Accessed 07-August-2024]."},{"key":"286_CR32","unstructured":"Saey TH. Here\u2019s why COVID-19 isn\u2019t seasonal so far. ScienceNews. [Accessed 07-August-2024]. https:\/\/www.sciencenews.org\/article\/why-covid-not-seasonal"},{"key":"286_CR33","unstructured":"Eustat. Trips, overnight stays and average travel time (days) of tourists from abroad to the Basque Country by month. 2016\u20132022. [Accessed 07-August-2024]. https:\/\/en.eustat.eus\/bankupx\/pxweb\/en\/DB\/-\/PX_132614_fe_mti_a_03.px\/"},{"issue":"7","key":"286_CR34","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41562-021-01122-8","volume":"5","author":"E Mathieu","year":"2021","unstructured":"Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, et al. A global database of COVID-19 vaccinations. Nat Hum Behav. 2021;5(7):947\u201353. https:\/\/doi.org\/10.1038\/s41562-021-01122-8.","journal-title":"Nat Hum Behav"},{"issue":"5","key":"286_CR35","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3390\/math9050566","volume":"9","author":"J Marco-Franco","year":"2021","unstructured":"Marco-Franco J, Pita-Barros P, Gonz\u00e1lez-de Juli\u00e1n S, Sabat I, Vivas-Consuelo D. Simplified Mathematical Modelling of uncertainty: cost-effectiveness of COVID-19 vaccines in Spain. Mathematics. 2021;9(5):566. https:\/\/doi.org\/10.3390\/math9050566.","journal-title":"Mathematics"},{"issue":"7","key":"286_CR36","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.vaccine.2020.12.078","volume":"39","author":"M Kohli","year":"2021","unstructured":"Kohli M, Maschio M, Becker D, Weinstein MC. The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization. Vaccine. 2021;39(7):1157\u201364. https:\/\/doi.org\/10.1016\/j.vaccine.2020.12.078.","journal-title":"Vaccine"},{"issue":"1","key":"286_CR37","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/14760584.2024.2323133","volume":"23","author":"M Nagano","year":"2024","unstructured":"Nagano M, Kamei K, Matsuda H, Takahashi C, Yang J, Wada K, et al. Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan. Expert Rev Vaccines. 2024;23(1):349\u201361. https:\/\/doi.org\/10.1080\/14760584.2024.2323133.","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"286_CR38","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.idm.2017.08","volume":"2","author":"G Chowell","year":"2017","unstructured":"Chowell G. Fitting dynamic models to epidemic outbreaks with quantified uncertainty: a primer for parameter uncertainty, identifiability, and forecasts. Infec Dis Model. 2017;2(3):379\u201398. https:\/\/doi.org\/10.1016\/j.idm.2017.08.","journal-title":"Infec Dis Model"}],"container-title":["Journal of Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-024-00286-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44197-024-00286-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-024-00286-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T21:10:33Z","timestamp":1727730633000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44197-024-00286-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["286"],"URL":"https:\/\/doi.org\/10.1007\/s44197-024-00286-6","relation":{},"ISSN":["2210-6014"],"issn-type":[{"type":"electronic","value":"2210-6014"}],"subject":[],"published":{"date-parts":[[2024,8,26]]},"assertion":[{"value":"12 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}